CDH1 and neoplasm: EMT plays a critical role in tumor invasiveness and metastasis, and pioglitazone enhanced E-cadherin expression while suppressing mesenchymal markers, thereby inhibiting EMT and reducing the metastatic potential of NSCLC [78].